Sturm, Ruger & Company (RGR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales were $130.8 million, down from $142.8 million in Q2 2023, with diluted EPS of $0.47, down from $0.91.
Net income for Q2 2024 was $8.3 million, a 48.9% decrease from $16.2 million in Q2 2023; EBITDA was $14.5 million, down from $25.3 million.
Six-month 2024 net sales totaled $267.6 million, with diluted EPS of $0.87, both lower than the prior year period.
Production increased 18% in Q2 2024 from Q1, following a reduction in force of about 80 employees in Q1 2024.
Quarterly dividend of $0.19 per share declared, representing about 40% of net income.
Financial highlights
Cash and short-term investments totaled $105.6 million as of June 29, 2024; cash provided by operations in H1 2024 was $26.1 million.
Gross profit for Q2 2024 was $29.2 million, down 23.6% year-over-year; gross margin declined to 22.3%.
Operating income for Q2 2024 was $9.0 million, down from $18.4 million in Q2 2023.
477,917 shares repurchased for $20.3 million in H1 2024, reducing outstanding shares by about 3%.
Capital expenditures were $10.4 million in H1 2024, with 2024 capex expected to total approximately $20 million.
Outlook and guidance
2024 capital expenditures are projected at about $20 million, focused on new products and facility improvements.
Management expects further operational improvements and additional new product launches in H2 2024.
Margin improvements anticipated from cost reductions and higher production.
No expectation of a significant demand spike ahead of the presidential election, but prepared for any scenario.
Quarterly dividend policy remains at about 40% of net income, subject to performance and cash needs.
Latest events from Sturm, Ruger & Company
- Board refresh and Ruger 2030 strategy drive strong returns and disciplined growth.RGR
Proxy filing24 Mar 2026 - Ruger’s board rebuffed Beretta’s control efforts, reinforcing governance and shareholder protections.RGR
Proxy Filing10 Mar 2026 - Beretta’s bid for board control prompts defensive measures and governance refreshment.RGR
Proxy Filing9 Mar 2026 - Board composition refreshed with new independent directors amid shareholder proposals.RGR
Proxy Filing3 Mar 2026 - Sales growth and innovation offset market declines, but profitability fell year-over-year.RGR
Q4 20252 Mar 2026 - Q3 2024 sales rose 1.2% to $122.3M, but EPS and net income declined on margin pressure.RGR
Q3 202417 Jan 2026 - Net income up 9.7% on flat sales, strong liquidity, and rising CapEx for innovation.RGR
Q1 202524 Dec 2025 - Q4 sales and earnings rebounded on new product strength and market share gains.RGR
Q4 202423 Dec 2025 - Board recommends director elections, auditor ratification, and executive pay policies for 2025.RGR
Proxy Filing1 Dec 2025